- Home
- CVX vs NVS Comparison
CVX vs NVS Comparison
Compare CVX & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVX
- NVS
- Stock Information
- Founded
- CVX 1879
- NVS 1895
- Country
- CVX United States
- NVS Switzerland
- Employees
- CVX N/A
- NVS N/A
- Industry
- CVX Integrated oil Companies
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- CVX Energy
- NVS Health Care
- Exchange
- CVX Nasdaq
- NVS Nasdaq
- Market Cap
- CVX 284.0B
- NVS 230.5B
- IPO Year
- CVX N/A
- NVS 1991
- Fundamental
- Price
- CVX $160.78
- NVS $103.05
- Analyst Decision
- CVX Buy
- NVS Hold
- Analyst Count
- CVX 17
- NVS 5
- Target Price
- CVX $174.27
- NVS $121.25
- AVG Volume (30 Days)
- CVX 7.3M
- NVS 1.4M
- Earning Date
- CVX 11-01-2024
- NVS 10-29-2024
- Dividend Yield
- CVX 4.05%
- NVS 3.66%
- EPS Growth
- CVX N/A
- NVS 130.53
- EPS
- CVX 9.06
- NVS 8.58
- Revenue
- CVX $191,689,000,000.00
- NVS $49,940,000,000.00
- Revenue This Year
- CVX $2.45
- NVS $10.04
- Revenue Next Year
- CVX N/A
- NVS $4.55
- P/E Ratio
- CVX $17.74
- NVS $11.70
- Revenue Growth
- CVX N/A
- NVS 8.92
- 52 Week Low
- CVX $135.37
- NVS $92.35
- 52 Week High
- CVX $167.11
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- CVX 68.49
- NVS 23.61
- Support Level
- CVX $154.53
- NVS $107.94
- Resistance Level
- CVX $162.38
- NVS $104.68
- Average True Range (ATR)
- CVX 2.35
- NVS 0.94
- MACD
- CVX 0.69
- NVS -0.53
- Stochastic Oscillator
- CVX 89.13
- NVS 6.51
About CVX Chevron Corporation
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.